IS6588A - Natríum-vetnis skiptis hindri af gerð 1 (NHE-1) - Google Patents

Natríum-vetnis skiptis hindri af gerð 1 (NHE-1)

Info

Publication number
IS6588A
IS6588A IS6588A IS6588A IS6588A IS 6588 A IS6588 A IS 6588A IS 6588 A IS6588 A IS 6588A IS 6588 A IS6588 A IS 6588A IS 6588 A IS6588 A IS 6588A
Authority
IS
Iceland
Prior art keywords
nhe
inhibitor
sodium
alternate type
hydrogen
Prior art date
Application number
IS6588A
Other languages
English (en)
Inventor
George Chen Weichao
David Cox Eric
Guzman-Perez Angel
Original Assignee
Pfizer Products, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products, Inc. filed Critical Pfizer Products, Inc.
Publication of IS6588A publication Critical patent/IS6588A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS6588A 2000-04-28 2002-10-21 Natríum-vetnis skiptis hindri af gerð 1 (NHE-1) IS6588A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28
PCT/IB2001/000277 WO2001083470A1 (en) 2000-04-28 2001-02-28 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Publications (1)

Publication Number Publication Date
IS6588A true IS6588A (is) 2002-10-21

Family

ID=22741697

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6567A IS6567A (is) 2000-04-28 2002-09-24 Natríum-vetnis skiptilati af gerð 1 (NHE-1)
IS6588A IS6588A (is) 2000-04-28 2002-10-21 Natríum-vetnis skiptis hindri af gerð 1 (NHE-1)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS6567A IS6567A (is) 2000-04-28 2002-09-24 Natríum-vetnis skiptilati af gerð 1 (NHE-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (is)
JP (1) JP2003531900A (is)
KR (1) KR20020093079A (is)
CN (1) CN1225466C (is)
AP (1) AP2002002651A0 (is)
AR (1) AR028375A1 (is)
AU (1) AU2001235896A1 (is)
BG (1) BG107139A (is)
BR (1) BR0110268A (is)
CA (1) CA2407535A1 (is)
CO (1) CO5221125A1 (is)
CR (1) CR6797A (is)
CZ (1) CZ20023408A3 (is)
DZ (1) DZ3310A1 (is)
EA (1) EA004882B1 (is)
EE (1) EE200200615A (is)
GT (1) GT200100064A (is)
HN (1) HN2001000042A (is)
HR (1) HRP20020851A2 (is)
HU (1) HUP0300651A2 (is)
IL (1) IL152075A0 (is)
IS (2) IS6567A (is)
MA (1) MA26897A1 (is)
MX (1) MXPA02010600A (is)
MY (1) MY133842A (is)
NO (1) NO20025132L (is)
NZ (1) NZ521348A (is)
OA (1) OA12256A (is)
PA (1) PA8513301A1 (is)
PE (1) PE20011270A1 (is)
PL (1) PL357765A1 (is)
SK (1) SK14872002A3 (is)
SV (1) SV2002000418A (is)
TN (1) TNSN01065A1 (is)
TR (1) TR200202439T2 (is)
UA (1) UA73348C2 (is)
UY (1) UY26680A1 (is)
WO (1) WO2001083470A1 (is)
YU (1) YU79602A (is)
ZA (1) ZA200208605B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436539A1 (en) * 2001-01-31 2002-08-08 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
MXPA04004685A (es) * 2001-12-19 2004-08-12 Pfizer Prod Inc Procedimientos para preparar inhibidores de tipo-1 de intercambiador sodio-hidrogeno.
EP1499317A1 (en) * 2002-05-02 2005-01-26 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
CA2515939A1 (en) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Novel compounds
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002504546A (ja) * 1998-02-27 2002-02-12 ファイザー・プロダクツ・インク 虚血の治療のためのｎ−［（置換５員ジもしくはトリアザ二不飽和環）カルボニル］グアニジン誘導体

Also Published As

Publication number Publication date
ZA200208605B (en) 2003-10-24
UY26680A1 (es) 2001-12-28
HRP20020851A2 (en) 2005-02-28
MXPA02010600A (es) 2003-03-10
CN1426404A (zh) 2003-06-25
GT200100064A (es) 2002-03-22
HN2001000042A (es) 2001-07-09
MA26897A1 (fr) 2004-12-20
YU79602A (en) 2006-05-25
CR6797A (es) 2004-05-17
EP1276737A1 (en) 2003-01-22
CO5221125A1 (es) 2002-11-28
IL152075A0 (en) 2003-05-29
BG107139A (bg) 2003-07-31
WO2001083470A1 (en) 2001-11-08
JP2003531900A (ja) 2003-10-28
MY133842A (en) 2007-11-30
NZ521348A (en) 2004-09-24
UA73348C2 (en) 2005-07-15
TR200202439T2 (tr) 2003-02-21
BR0110268A (pt) 2003-12-30
EE200200615A (et) 2004-04-15
PL357765A1 (en) 2004-07-26
SV2002000418A (es) 2002-07-03
AR028375A1 (es) 2003-05-07
AU2001235896A1 (en) 2001-11-12
PE20011270A1 (es) 2001-12-12
PA8513301A1 (es) 2003-09-05
NO20025132L (no) 2002-12-12
OA12256A (en) 2003-11-06
AP2002002651A0 (en) 2002-12-31
CA2407535A1 (en) 2001-11-08
CZ20023408A3 (cs) 2004-01-14
CN1225466C (zh) 2005-11-02
DZ3310A1 (fr) 2001-11-07
KR20020093079A (ko) 2002-12-12
EA200201023A1 (ru) 2003-02-27
HUP0300651A2 (hu) 2003-07-28
SK14872002A3 (sk) 2004-03-02
NO20025132D0 (no) 2002-10-25
TNSN01065A1 (fr) 2005-11-10
IS6567A (is) 2002-09-24
EA004882B1 (ru) 2004-08-26

Similar Documents

Publication Publication Date Title
DK1064298T3 (da) Inhibitorer af caspaser
NO20030845L (no) Utvalgte kondenserte pyrrolokarbazoler
ATE398611T1 (de) Para-amin substituierte phenylamid glukokinase activatoren
DZ3318A1 (fr) Inhibiteur de proteinase
DE50103020D1 (de) Positioniereinheit
ATE307121T1 (de) Substituierte arylpyrazine
DE60112603D1 (de) Perkutane aortenklappe
AR028393A1 (es) Iminoazidas substituidas
DE50110260D1 (de) Kühlkreislauf
FI20002408L (fi) Jäähdytyselementti
DE60130271D1 (de) Werstückträger
DE50007505D1 (de) Positioniervorrichtung
AR028302A1 (es) Feniluracilos substituidos
NO20025132D0 (no) Natrium-hydrogen-byttertype 1-inhibitor (NHE-1)
DE60127966D1 (de) Schaltungsanordnung
DE60132814D1 (de) Te
DE69903779D1 (de) Inhibitor- Schalter
DE60122192D1 (de) Schaltungsanordnung
DE60112941D1 (de) Schaltungsanordnung
DE60117837D1 (de) Schaltungsanordnung
DE50108778D1 (de) Dialkinverbindungen
DE60113842D1 (de) Schaltung
FI20000264L (fi) Aikakauslehtipaperi
NO20000210D0 (no) Spannholder
FI20000385A0 (fi) ISDN-kuulostus